---
title: "Weigao Orthopaedic released its 2024 annual performance, with a net profit attributable to the parent company of 224 million yuan, a year-on-year increase of 99.22%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233285584.md"
description: "Weigao Orthopaedic released its 2024 annual report, with operating revenue of 1.453 billion yuan, a year-on-year increase of 13.18%; net profit attributable to the parent company was 224 million yuan, a year-on-year increase of 99.22%. The net profit excluding non-recurring gains and losses was 211 million yuan, a year-on-year increase of 95.44%. The basic earnings per share were 0.56 yuan, and it is proposed to distribute a cash dividend of 1.70 yuan for every 10 shares. The company has increased its market share and achieved performance growth by adjusting its business strategy and optimizing management"
datetime: "2025-03-26T12:29:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233285584.md)
  - [en](https://longbridge.com/en/news/233285584.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233285584.md)
---

# Weigao Orthopaedic released its 2024 annual performance, with a net profit attributable to the parent company of 224 million yuan, a year-on-year increase of 99.22%

According to the Zhitong Finance APP, Weigao Orthopaedic (688161.SH) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 1.453 billion yuan, a year-on-year increase of 13.18%. The net profit attributable to shareholders of the listed company was 224 million yuan, a year-on-year increase of 99.22%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 211 million yuan, a year-on-year increase of 95.44%. The basic earnings per share were 0.56 yuan. It is proposed to distribute a cash dividend of 1.70 yuan (including tax) for every 10 shares to all shareholders.

During the reporting period, the volume-based procurement of orthopedic consumables was executed smoothly. The company actively adjusted its business strategy, comprehensively increased market share and customer coverage, while strengthening refined performance management, optimizing the marketing structure and inventory management, improving supply chain efficiency, and reducing the sales expense ratio, achieving performance growth for this reporting period

### Related Stocks

- [688161.CN](https://longbridge.com/en/quote/688161.CN.md)

## Related News & Research

- [BPCL plans ₹25,000 crore capex for FY27, calls fuel price hike respite](https://longbridge.com/en/news/286942050.md)
- [Intel CEO says foundry business is gaining momentum as customer interest grows](https://longbridge.com/en/news/286826548.md)
- [02:50 ETPowerbox wprowadza na rynek serię wytrzymałych przetworników DC/DC do zastosowań w sektorze obronnym](https://longbridge.com/en/news/286867266.md)
- [LG CNS Expands North American AX Business, Supporting Smart Factory Transformation for SMEs](https://longbridge.com/en/news/286971453.md)
- [15:33 ETBLUETTI на WUF13 -- партнерство с UN-Habitat для глобальной устойчивой урбанизации](https://longbridge.com/en/news/286957888.md)